Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38716552)

  • 1. Fisetin from Dietary Supplement to a Drug Candidate: An Assessment of Potential.
    Mirza MA; Padhi S; Mohapatra S; Mahmood S; Iqbal Z
    Curr Pharm Biotechnol; 2024 Apr; ():. PubMed ID: 38716552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the molecular targets of dietary flavonoid fisetin in cancer.
    Syed DN; Adhami VM; Khan N; Khan MI; Mukhtar H
    Semin Cancer Biol; 2016 Oct; 40-41():130-140. PubMed ID: 27163728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine.
    Mehta P; Pawar A; Mahadik K; Bothiraja C
    Biomed Pharmacother; 2018 Oct; 106():1282-1291. PubMed ID: 30119198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies.
    Qaed E; Al-Hamyari B; Al-Maamari A; Qaid A; Alademy H; Almoiliqy M; Munyemana JC; Al-Nusaif M; Alafifi J; Alyafeai E; Safi M; Geng Z; Tang Z; Ma X
    Glob Med Genet; 2023 Sep; 10(3):205-220. PubMed ID: 37565061
    [No Abstract]   [Full Text] [Related]  

  • 5. Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead.
    Vishwas S; Singh SK; Gulati M; Awasthi A; Khursheed R; Corrie L; Kumar R; Collet T; Loebenberg R; Porwal O; Gupta S; Jha NK; Gupta PK; Devkota HP; Chellappan DK; Gupta G; Adams J; Dua K
    Chem Biol Interact; 2022 Apr; 356():109869. PubMed ID: 35231453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin.
    Rauf A; Abu-Izneid T; Imran M; Hemeg HA; Bashir K; Aljohani ASM; Aljohani MSM; Alhumaydhi FA; Khan IN; Bin Emran T; Gondal TA; Nath N; Ahmad I; Thiruvengadam M
    Curr Top Med Chem; 2023; 23(21):2075-2096. PubMed ID: 37431899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.
    Adhami VM; Syed DN; Khan N; Mukhtar H
    Biochem Pharmacol; 2012 Nov; 84(10):1277-81. PubMed ID: 22842629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fisetin-In Search of Better Bioavailability-From Macro to Nano Modifications: A Review.
    Szymczak J; Cielecka-Piontek J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fisetin: An anticancer perspective.
    Imran M; Saeed F; Gilani SA; Shariati MA; Imran A; Afzaal M; Atif M; Tufail T; Anjum FM
    Food Sci Nutr; 2021 Jan; 9(1):3-16. PubMed ID: 33473265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways.
    Rengarajan T; Yaacob NS
    Eur J Pharmacol; 2016 Oct; 789():8-16. PubMed ID: 27377217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eugenol as a Potential Drug Candidate: A Review.
    Taleuzzaman M; Jain P; Verma R; Iqbal Z; Mirza MA
    Curr Top Med Chem; 2021; 21(20):1804-1815. PubMed ID: 34218781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin: a dietary antioxidant for health promotion.
    Khan N; Syed DN; Ahmad N; Mukhtar H
    Antioxid Redox Signal; 2013 Jul; 19(2):151-62. PubMed ID: 23121441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile.
    Singh S; Sharma A; Monga V; Bhatia R
    Crit Rev Food Sci Nutr; 2023; 63(27):8868-8899. PubMed ID: 35357240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics.
    Kumar RM; Kumar H; Bhatt T; Jain R; Panchal K; Chaurasiya A; Jain V
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fisetin and Its Role in Chronic Diseases.
    Pal HC; Pearlman RL; Afaq F
    Adv Exp Med Biol; 2016; 928():213-244. PubMed ID: 27671819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury-A systematic review.
    Prem PN; Sivakumar B; Boovarahan SR; Kurian GA
    Phytomedicine; 2022 Jul; 101():154123. PubMed ID: 35533608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of synthesized fisetin glucoside by dextransucrase from Leuconostoc mesenteroides NRRL B-1299CB4 with enhanced water solubility.
    Moon Y; Kim H; Kang CG; Park C; Kim SW; Kim D
    Enzyme Microb Technol; 2022 Nov; 161():110111. PubMed ID: 35961060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Fisetin in Selected Malignant Neoplasms in Women.
    Markowska A; Antoszczak M; Kacprzak K; Markowska J; Huczyński A
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials.
    Mangla B; Javed S; Sultan MH; Kumar P; Kohli K; Najmi A; Alhazmi HA; Al Bratty M; Ahsan W
    Phytother Res; 2021 Oct; 35(10):5440-5458. PubMed ID: 34184327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.